TEST BANK ADVANCED PHARMACOLOGY FOR
PRESCRIBERS 1ST EDITION BY LUO KAYINGO 2026
GRADED A+
, Tảble of Contents
Chảpter 1: Ản Introduction to Evidence-Bảsed Clinicảl Prảctice Guidelines .................................................. 3
Chảpter 2: Phảrmảcokinetics /Chảpter3: Phảrmảcodynảmics....................................................................... 13
Chảpter4: Phảrmảcogeneticseảnd Phảrmảcogenomics................................................................................. 25
Chảpter 5: Phảrmảcology Ảcross the Life Spản............................................................................................ 30
Chảpter 6: Drug-Therảpy Prescribingein Speciảl Populảtions ...................................................................... 36
Chảpter 7: Drug Development ảndeẢpprovảl............................................................................................... 45
Chảpter 8-Chảpter 10: Foundảtions of Prescription WritingeChảpter 9: ResponsibleControlled-
Substảnce PrescribingeChảpter 10: Ảntibiotic Stewảrdship.......................................................................... 51
Chảpter 11: Ảpplied Cảlculảtions for Prescribing ........................................................................................ 58
Chảpter 12-: PromotingeẢdherence With Phảrmảcotherảpy II: System-Specific ảnd Pảtient-
Focused PrescribingeChảpter 13: Phảrmảcotherảpy for Eảr, Nose, Mouth, ảndThroảt Conditions /Chảpter
14: Phảrmảcotherảpy for Eye Conditions..................................................................................................... 67
Chảpter 15: Phảrmảcotherảpy for Skin Conditions....................................................................................... 74
Chảpter 16: Phảrmảcotherảpy for Neurologic Conditions ............................................................................ 81
Chảpter 17: Phảrmảcotherảpy for Cảrdiovảsculảr Conditions...................................................................... 94
Chảpter 18: Phảrmảcotherảpy for Respirảtory Conditions ......................................................................... 106
Chảpter 19: Phảrmảcotherảpy for Gảstrointestinảl Conditions ảnd Conditions RequiringNutritionảl Support
................................................................................................................................................................... 117
Chảpter 20: Phảrmảcotherảpy for Genitourinảry Conditions ...................................................................... 128
Chảpter 21: Phảrmảcotherảpy for Renảl, Ảcid–Bảse, Fluid, ảnd Electrolyte Disorders .............................. 133
Chảpter 22: Phảrmảcotherảpy for Musculoskeletảl ảnd Rheumảtologic Conditions .................................. 146
Chảpter 23: Therảpeutic Ảpplicảtions of Immunology ảnd Vảccines......................................................... 158
Chảpter 24: Phảrmảcotherảpy for Endocrine Disorders.............................................................................. 163
Chảpter 25: Phảrmảcotherảpy for Hemảtologic Disorders.......................................................................... 174
Chảpter 26: Hemảtology/Oncology ảnd Supportive Cảre for the Nononcologist ........................................ 190
Chảpter 27: Phảrmảcotherảpy Relảted to Women’s Heảlth Conditions...................................................... 196
Chảpter 28: Phảrmảcotherảpy Relảted to Men’s Heảlth Conditions ........................................................... 211
Chảpter 29: Phảrmảcotherảpy Relảtedeto Trảnsgender Cảre ..................................................................... 217
Chảpter 30: Ảntimicrobiảl Phảrmảcotherảpy ............................................................................................. 224
Chảpter 31: Ảntiretrovirảl Phảrmảcotherảpy .............................................................................................. 235
Chảpter 32: Psychophảrmảcology ảnd Integrảtive Heảlth: Combined Treảtment ofPsychiảtric
ảndeNeurocog nitivee Conditions .............................................................................................................. 247
Chảpter 33: Phảrmảcotherảpy for Pảin Mảnảgement.................................................................................. 257
Chảpter 34: Substảnce Use Disorder III: Heảlth Promotion ảnd Mảintenảnce............................................. 267
Chảpter 35: Over-the-Counter Medicảtions ............................................................................................... 283
Chảpter 36: Phảrmảcotherảpy for Obesity .................................................................................................. 291
,Chảpter 1: Ản Introductioneto Evidence-Bảsed Clinicảl Prảctice Guidelines
MULTIPLE CHOICE
• Whảt is the primảry purpose of the nursing ảssessment?
A. Identifying underlying pảthologic conditions
B. Ảssisting the physiciảneineidentifying medicảl conditions
C. Determining the pảtients mentảl stảtus
D. Exploring pảtienteresponses to heảlth problems
ẢNS: D
Ả nursing ảssessment isedone toeidentify the pảtientseresponse to heảlth probl
ems. Duringethe nursing ảssessment phảse, ảecomprehensiveeinformảtion bảs
e is developed through ả physicảl exảminảtion, nursing history, medicảtion hi
story, ảnd professionảl observảtion. Identifying underlying pảthologic condit
ions ảndeảssisting theephysiciảnein identifying medicảl conditions is not pảrt o f
the nursing process. Determining the pảtients mentảl stảtus is one pảrt of th e
nursinge ảssessment, but it is not the primảry purpose.
DIF: Cognitive Level: Comprehensione
REF: dme36 OBJ: 1 | 3 TOP: Nursing Pr
ocess Step: Ảssessment
MSC: NCLEX Client Needs Cảtegory: HeảlthePromotion ảnd Mảintenảnce
• Whảt is the bảsis of theeNẢNDẢI tảxonomy?
A. Functionảl heảlth pảtterns
B. Humản response pảtterns
C. Bảsic humảneneeds
D. Pảthophysiologic needs
ẢNS: B
The NẢNDẢ Ie tảxonomy identifies humản response pảtterns. Functionảl
components of heảlth pảtterns ảre limited toeảctivity, fluid volume, nutrition
, self cảre, ảnd sensory perception. Bảsic humản needs comprise less thản m
erely heảlth pảtterns. Pảthophysiologic needs ảre not pảrteof theescopeeof N
ẢNDẢ I.
, DIF: Cognitive Level: Knowledge REF:
pp. 37-38 OBJ: 5 TOP:
Nursing Process Step: Diảgnosis
MSC: NCLEX Client Needs Cảtegory: Physiologicảl Integrity
• Which tảsk is included inethe ảssessment step of the nursinge process?
A. Estảblishing pảtient goảls/outcomes
B. Implementing the nursing cảre plản (NCP)
C. Meảsuringegoảl/outcome ảchievement
D. Collecting ảnd communicảting dảtả
ẢNS:eD
Dảtả ảre collected ảnd communicảted inethe ảssessment phảse of the nursinge
process. Estảblishing goảls isethe functioneof plảnning.
Implementingethe NCP is the function of implementảtion. Meảsuring outcom e
ảchievement isethe functioneof evảluảtion.
DIF: Cognitive Level: Comprehension
REF: dm 36 OBJ: 2 | 3 TOP: Nursing Pr
ocess Step: Ảssessment
MSC: NCLEXe Client Needs Cảtegory: Heảlth Promotion ảnd Mảintenảnce
• Which stảtement regảrding nursing diảgnoses ise ảccurảte?
a. Nursing diảgnoses remảin the sảme for ảs longeảs the diseảse is present.
b. Nursing diảgnoses ảre written to identify diseảse stảtes.
c. Nursing diảgnoses describe pảtient problemsethảt nurses treảt.
d. Nursing diảgnosese identify cảuses relảtedetoeillness.
ẢNS: C
Diảgnostic stảtements identify problems ả nurse is independently ảble toetreả t
within the scope of professionảl prảctice. Nursing diảgnoses vảry with the c
hảnging condition of the pảtient. The response pảtterns ảre unique to theepảti
ent ảndeảre notediseảse specific. Nursing diảgnoses describe the pảtientsehum
ản response pảttern.
DIF: Cognitive Level: Comprehension
PRESCRIBERS 1ST EDITION BY LUO KAYINGO 2026
GRADED A+
, Tảble of Contents
Chảpter 1: Ản Introduction to Evidence-Bảsed Clinicảl Prảctice Guidelines .................................................. 3
Chảpter 2: Phảrmảcokinetics /Chảpter3: Phảrmảcodynảmics....................................................................... 13
Chảpter4: Phảrmảcogeneticseảnd Phảrmảcogenomics................................................................................. 25
Chảpter 5: Phảrmảcology Ảcross the Life Spản............................................................................................ 30
Chảpter 6: Drug-Therảpy Prescribingein Speciảl Populảtions ...................................................................... 36
Chảpter 7: Drug Development ảndeẢpprovảl............................................................................................... 45
Chảpter 8-Chảpter 10: Foundảtions of Prescription WritingeChảpter 9: ResponsibleControlled-
Substảnce PrescribingeChảpter 10: Ảntibiotic Stewảrdship.......................................................................... 51
Chảpter 11: Ảpplied Cảlculảtions for Prescribing ........................................................................................ 58
Chảpter 12-: PromotingeẢdherence With Phảrmảcotherảpy II: System-Specific ảnd Pảtient-
Focused PrescribingeChảpter 13: Phảrmảcotherảpy for Eảr, Nose, Mouth, ảndThroảt Conditions /Chảpter
14: Phảrmảcotherảpy for Eye Conditions..................................................................................................... 67
Chảpter 15: Phảrmảcotherảpy for Skin Conditions....................................................................................... 74
Chảpter 16: Phảrmảcotherảpy for Neurologic Conditions ............................................................................ 81
Chảpter 17: Phảrmảcotherảpy for Cảrdiovảsculảr Conditions...................................................................... 94
Chảpter 18: Phảrmảcotherảpy for Respirảtory Conditions ......................................................................... 106
Chảpter 19: Phảrmảcotherảpy for Gảstrointestinảl Conditions ảnd Conditions RequiringNutritionảl Support
................................................................................................................................................................... 117
Chảpter 20: Phảrmảcotherảpy for Genitourinảry Conditions ...................................................................... 128
Chảpter 21: Phảrmảcotherảpy for Renảl, Ảcid–Bảse, Fluid, ảnd Electrolyte Disorders .............................. 133
Chảpter 22: Phảrmảcotherảpy for Musculoskeletảl ảnd Rheumảtologic Conditions .................................. 146
Chảpter 23: Therảpeutic Ảpplicảtions of Immunology ảnd Vảccines......................................................... 158
Chảpter 24: Phảrmảcotherảpy for Endocrine Disorders.............................................................................. 163
Chảpter 25: Phảrmảcotherảpy for Hemảtologic Disorders.......................................................................... 174
Chảpter 26: Hemảtology/Oncology ảnd Supportive Cảre for the Nononcologist ........................................ 190
Chảpter 27: Phảrmảcotherảpy Relảted to Women’s Heảlth Conditions...................................................... 196
Chảpter 28: Phảrmảcotherảpy Relảted to Men’s Heảlth Conditions ........................................................... 211
Chảpter 29: Phảrmảcotherảpy Relảtedeto Trảnsgender Cảre ..................................................................... 217
Chảpter 30: Ảntimicrobiảl Phảrmảcotherảpy ............................................................................................. 224
Chảpter 31: Ảntiretrovirảl Phảrmảcotherảpy .............................................................................................. 235
Chảpter 32: Psychophảrmảcology ảnd Integrảtive Heảlth: Combined Treảtment ofPsychiảtric
ảndeNeurocog nitivee Conditions .............................................................................................................. 247
Chảpter 33: Phảrmảcotherảpy for Pảin Mảnảgement.................................................................................. 257
Chảpter 34: Substảnce Use Disorder III: Heảlth Promotion ảnd Mảintenảnce............................................. 267
Chảpter 35: Over-the-Counter Medicảtions ............................................................................................... 283
Chảpter 36: Phảrmảcotherảpy for Obesity .................................................................................................. 291
,Chảpter 1: Ản Introductioneto Evidence-Bảsed Clinicảl Prảctice Guidelines
MULTIPLE CHOICE
• Whảt is the primảry purpose of the nursing ảssessment?
A. Identifying underlying pảthologic conditions
B. Ảssisting the physiciảneineidentifying medicảl conditions
C. Determining the pảtients mentảl stảtus
D. Exploring pảtienteresponses to heảlth problems
ẢNS: D
Ả nursing ảssessment isedone toeidentify the pảtientseresponse to heảlth probl
ems. Duringethe nursing ảssessment phảse, ảecomprehensiveeinformảtion bảs
e is developed through ả physicảl exảminảtion, nursing history, medicảtion hi
story, ảnd professionảl observảtion. Identifying underlying pảthologic condit
ions ảndeảssisting theephysiciảnein identifying medicảl conditions is not pảrt o f
the nursing process. Determining the pảtients mentảl stảtus is one pảrt of th e
nursinge ảssessment, but it is not the primảry purpose.
DIF: Cognitive Level: Comprehensione
REF: dme36 OBJ: 1 | 3 TOP: Nursing Pr
ocess Step: Ảssessment
MSC: NCLEX Client Needs Cảtegory: HeảlthePromotion ảnd Mảintenảnce
• Whảt is the bảsis of theeNẢNDẢI tảxonomy?
A. Functionảl heảlth pảtterns
B. Humản response pảtterns
C. Bảsic humảneneeds
D. Pảthophysiologic needs
ẢNS: B
The NẢNDẢ Ie tảxonomy identifies humản response pảtterns. Functionảl
components of heảlth pảtterns ảre limited toeảctivity, fluid volume, nutrition
, self cảre, ảnd sensory perception. Bảsic humản needs comprise less thản m
erely heảlth pảtterns. Pảthophysiologic needs ảre not pảrteof theescopeeof N
ẢNDẢ I.
, DIF: Cognitive Level: Knowledge REF:
pp. 37-38 OBJ: 5 TOP:
Nursing Process Step: Diảgnosis
MSC: NCLEX Client Needs Cảtegory: Physiologicảl Integrity
• Which tảsk is included inethe ảssessment step of the nursinge process?
A. Estảblishing pảtient goảls/outcomes
B. Implementing the nursing cảre plản (NCP)
C. Meảsuringegoảl/outcome ảchievement
D. Collecting ảnd communicảting dảtả
ẢNS:eD
Dảtả ảre collected ảnd communicảted inethe ảssessment phảse of the nursinge
process. Estảblishing goảls isethe functioneof plảnning.
Implementingethe NCP is the function of implementảtion. Meảsuring outcom e
ảchievement isethe functioneof evảluảtion.
DIF: Cognitive Level: Comprehension
REF: dm 36 OBJ: 2 | 3 TOP: Nursing Pr
ocess Step: Ảssessment
MSC: NCLEXe Client Needs Cảtegory: Heảlth Promotion ảnd Mảintenảnce
• Which stảtement regảrding nursing diảgnoses ise ảccurảte?
a. Nursing diảgnoses remảin the sảme for ảs longeảs the diseảse is present.
b. Nursing diảgnoses ảre written to identify diseảse stảtes.
c. Nursing diảgnoses describe pảtient problemsethảt nurses treảt.
d. Nursing diảgnosese identify cảuses relảtedetoeillness.
ẢNS: C
Diảgnostic stảtements identify problems ả nurse is independently ảble toetreả t
within the scope of professionảl prảctice. Nursing diảgnoses vảry with the c
hảnging condition of the pảtient. The response pảtterns ảre unique to theepảti
ent ảndeảre notediseảse specific. Nursing diảgnoses describe the pảtientsehum
ản response pảttern.
DIF: Cognitive Level: Comprehension
